FN2 Earnings Intelligence
Humana Inc. financials
Humana Inc. (HUM) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $3,394 | $5,061 | $4,694 | $2,221 | $4,200 | - | - |
| + Debt | $12,494 | $11,126 | $11,656 | $11,721 | $12,369 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $83,064 | $92,870 | $106,374 | $117,761 | $129,664 | $162,158.2 | $169,292.7 |
| % Growth | 7.7% | 11.8% | 14.5% | 10.7% | 10.1% | 25.1% | 4.4% |
| Gross Profit | $3,148 | $3,800 | $4,013 | $2,562 | $2,704 | - | - |
| % Margin | 3.8% | 4.1% | 3.8% | 2.2% | 2.1% | - | - |
| EBITDA | $3,788 | $4,549 | $4,792 | $3,401 | $3,402 | - | - |
| % Margin | 4.6% | 4.9% | 4.5% | 2.9% | 2.6% | - | - |
| Net Income | $2,933 | $2,806 | $2,489 | $1,207 | $1,188 | - | - |
| % Margin | 3.5% | 3.0% | 2.3% | 1.0% | 0.9% | - | - |
| Diluted EPS | $22.67 | $22.08 | $20.00 | $9.98 | $9.84 | $8.98 | $16.16 |
| % Growth | -10.4% | -2.6% | -9.4% | -50.1% | -1.4% | -8.7% | 79.9% |
| Operating Cash Flow | $2,262 | $4,587 | $3,981 | $2,966 | $921 | - | - |
| CapEx | $1,316 | $1,120 | $1,004 | $575 | $546 | - | - |
| Free Cash Flow | $946 | $3,467 | $2,977 | $2,391 | $375 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $83,064 | $92,870 | $106,374 | $117,761 | $129,664 | $162,158.2 | $169,292.7 |
| Gross Profit | $3,148 | $3,800 | $4,013 | $2,562 | $2,704 | - | - |
| EBITDA | $3,788 | $4,549 | $4,792 | $3,401 | $3,402 | - | - |
| Net Income | $2,933 | $2,806 | $2,489 | $1,207 | $1,188 | - | - |
| Diluted EPS | $22.67 | $22.08 | $20.00 | $9.98 | $9.84 | $8.98 | $16.16 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $3,394 | $5,061 | $4,694 | $2,221 | $4,200 |
| Short-term Debt | $1,953 | $2,092 | $1,443 | $577 | $0 |
| Long-term Debt | $10,541 | $9,034 | $10,213 | $11,144 | $12,369 |
| Total Debt | $12,494 | $11,126 | $11,656 | $11,721 | $12,369 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $2,262 | $4,587 | $3,981 | $2,966 | $921 |
| Capital Expenditure | $1,316 | $1,120 | $1,004 | $575 | $546 |
| Free Cash Flow | $946 | $3,467 | $2,977 | $2,391 | $375 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 7.7% | 11.8% | 14.5% | 10.7% | 10.1% |
| Gross Margin | 3.8% | 4.1% | 3.8% | 2.2% | 2.1% |
| EBITDA Margin | 4.6% | 4.9% | 4.5% | 2.9% | 2.6% |
| Net Margin | 3.5% | 3.0% | 2.3% | 1.0% | 0.9% |
| FCF Margin | 1.1% | 3.7% | 2.8% | 2.0% | 0.3% |
| Diluted EPS Growth | -10.4% | -2.6% | -9.4% | -50.1% | -1.4% |